Effect of CRP and SAA Point-of-care Testing on Antibiotic Prescribing for Acute Respiratory-tract Infections

ConditionAntibiotic Prescribing for Acute Respiratory-tract Infections

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

AgeNot listed

SponsorHuazhong University of Science and Technology

About this trial

The study was a practical, cluster-randomized controlled trial to evaluate the impact of CRP and SAA point-of-care testing (CRP\&SAA POCT) on antibiotic prescribing in patients with acute respiratory-tract infections (ARI) at primary care facilities in rural China.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

CRP+SAA POCT

Treatment groups

19,424 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Huazhong University of Science and Technology

Lead sponsor

University of Toronto

Collaborator

Source ClinicalTrials.gov